0
1

[–] Allrightsreserved 0 points 1 point (+1|-0) ago 

ANAVEX 2-73, the Company’s lead investigational oral treatment for Alzheimer’s targeting sigma-1 and muscarinic receptors, which is believed to reduce protein misfolding including reduction of beta amyloid, tau and inflammation. I hope the trials will prove this drug to be effective. The current treatments are woefully inadequate.

0
1

[–] Imapopulistnow [S] 0 points 1 point (+1|-0) ago 

faster, please...